Cite
Tazawa H, Suzuki T, Saito A, et al. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. J Gastrointest Surg. 2021;doi: 10.1007/s11605-021-05101-2.
Tazawa, H., Suzuki, T., Saito, A., Ishikawa, A., Komo, T., Sada, H., Shimada, N., Hadano, N., Onoe, T., Sudo, T., Shimizu, Y., Kuraoka, K., & Tashiro, H. (2021). Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, . https://doi.org/10.1007/s11605-021-05101-2
Tazawa, Hirofumi, et al. "Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer." Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract vol. (2021). doi: https://doi.org/10.1007/s11605-021-05101-2
Tazawa H, Suzuki T, Saito A, Ishikawa A, Komo T, Sada H, Shimada N, Hadano N, Onoe T, Sudo T, Shimizu Y, Kuraoka K, Tashiro H. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. J Gastrointest Surg. 2021 Aug 11; doi: 10.1007/s11605-021-05101-2. Epub 2021 Aug 11. PMID: 34379296.
Copy
Download .nbib